Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Assessing the pros and cons of zero based budgeting can guide your financial planning. Discover what works best for your situation.
28,655 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
AI is accelerating the pace at which startups reach unicorn status, with policy shifts and market volatility adding c...
Google's Gemini AI offers a bold Solana forecast for late 2026. The model sees a possible move up to $150-$200 if Fir...
Elon Musk’s wealth dipped below $1 trillion as SpaceX valuations cooled, triggering market chatter and a Wisconsin in...
Vanguard Industrials ETF (VIS) delivers a focused bet on the industrials complex with a low-cost 0.10% fee. The fund ...
A federal appeals court rejects the DOJ's bid to delay the tariff refund program, speeding relief for millions of tax...
Ally Financial is off to a challenging start in 2026, with shares down as inflation and tariff risks bite auto lendin...
Hims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
A rare misfire during a live-fire demonstration over Camp Pendleton unleashed shrapnel on California's I-5. The Marin...
The median age for first-time buyers climbed to a record 40, with Zillow’s chief executive warning relief from high c...
Take-Two’s leader is steering a record $1.5 billion bet on GTA VI, illustrating how blockbuster launches shape person...
Colgate-Palmolive posted stronger-than-expected Q1 2026 results, setting the stage for upside despite tariff headwind...